What is red biotechnology?

Red Biotechnologists is an industry of biotechnology, which deals specifically by the care of human health and treatment methods through the development of medicinal products such as antibiotics. The field may also include research into gene manipulation through germics engineering at an embryonic stage or gene therapy in adult patients. The focus of red biotechnology is usually in the pharmaceutical sector, which is estimated that 80% of all biotechnological discoveries have been carried out since 2011. Biotechnology has become a very wide area of ​​scientific research and treatment and authorities and authorities and authorities. This has led to the field to be divided into several subordinate fields identified by color, including green, blue, white and gray biotechnology. Blue biotechnology is limited to the sea environment, while Green Biotechnology is focused on agricultural applications. White Biotechnology has an industrial base that includes an organic enzYmy and processes that make it easier, and gray biotechnology has a similar basis where cells and natural organisms are used to create synthetic compounds.

China is considered a leading research arena in the field of red biotechnology and is involved in the development of everything from blood -related products and drugs that affect the body at the genetic level. Since the beginning of 2010, the nation has been marketing over 20 blood products for international communities such as immunoglobulin. Research includes the production of diagnostic substances in the first three main areas of immunology, molecular diagnostics and biochemical diagnostics, as well as the studies of stem cells, antibodies and others. China is also a leading vaccine manufacturer worldwide and produces millions per year.

Since Red Biotechnologists has pure research and practical medical applications, it is often based on laboratory production of basic biologistof the materials. Proteins, gene expression and antibodies are studied as vectors that can be used to create genetically modified cells or whole organisms such as yeast or bacteria that can be created to generate medicines and insulin to treat patients with diabetes. Proteins have also been changed to support the production of enzymes in convulsions that can be used in the treatment of human heart disease. The development of such drugs as in cancer treatment is increasingly extremely toxic at normal size doses and must be administered in a minute, carefully controlled quantities to be effective medical treatment. As a result, nanotechnological research is also an important aspect of red biotechnology.

The

field of red biotechnology involves the creation of new forms of drugs or cellular treatment for age diseases such as tuberculosis and resistant strains of malaria or viruses that do not respond to traditional antibiotics. This is an inclusive areaResearch that includes basic science into biological processes, diagnostic methods for detecting disease and treatment in both conventional forms such as medicine or advanced forms such as genetic manipulation. Red Biotechnology uses this graded approach to attempting to solve some of the most widely used humanity diseases, from hepatitis and AIDS to suppress resistant tribes of the influenza virus.